前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：202002227143105449
整理番号：20A2254132
半数体造血幹細胞移植後の異なるサイトメガロウイルス疾患の比較【JST・京大機械翻訳】
Comparison of different cytomegalovirus diseases following haploidentical hematopoietic stem cell transplantation
Meng Xing-Ye
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Meng Xing-Ye
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Meng Xing-Ye
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Meng Xing-Ye
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Fu Hai-Xia
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Fu Hai-Xia
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Fu Hai-Xia
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Fu Hai-Xia
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Zhu Xiao-Lu
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Zhu Xiao-Lu
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Zhu Xiao-Lu
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Zhu Xiao-Lu
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Wang Jing-Zhi
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Wang Jing-Zhi
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Wang Jing-Zhi
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Wang Jing-Zhi
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Liu Xiao
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Liu Xiao
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Liu Xiao
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Liu Xiao
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Yan Chen-Hua
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Yan Chen-Hua
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Yan Chen-Hua
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Yan Chen-Hua
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Zhang Yuan-Yuan
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Zhang Yuan-Yuan
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Zhang Yuan-Yuan
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Zhang Yuan-Yuan
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Mo Xiao-Dong
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Mo Xiao-Dong
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Mo Xiao-Dong
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Mo Xiao-Dong
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Wang Yu
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Wang Yu
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Wang Yu
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Wang Yu
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Han Wei
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Han Wei
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Han Wei
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Han Wei
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Chen Yu-Hong
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Chen Yu-Hong
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Chen Yu-Hong
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Chen Yu-Hong
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Chen Ding-Bao
(Department of Pathology, Peking University People’s Hospital, Beijing, China)
,
Liu Hui-Xin
(Department of Clinical Epidemiology and Biostatistics, Peking University People’s Hospital, Beijing, China)
,
Chang Ying-Jun
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Chang Ying-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Chang Ying-Jun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Chang Ying-Jun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Xu Lan-Ping
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Xu Lan-Ping
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Xu Lan-Ping
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Xu Lan-Ping
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Liu Kai-Yan
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Liu Kai-Yan
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Liu Kai-Yan
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Liu Kai-Yan
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Huang Xiao-Jun
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Huang Xiao-Jun
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Huang Xiao-Jun
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Huang Xiao-Jun
(National Clinical Research Center for Hematologic Disease, Beijing, China)
,
Zhang Xiao-Hui
(Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China)
,
Zhang Xiao-Hui
(Collaborative Innovation Center of Hematology, Peking University, Beijing, China)
,
Zhang Xiao-Hui
(Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China)
,
Zhang Xiao-Hui
(National Clinical Research Center for Hematologic Disease, Beijing, China)
資料名：
Annals of Hematology
(Annals of Hematology)
巻： 99 号： 11 ページ： 2659-2670 発行年： 2020年
JST資料番号： W4037A ISSN： 0939-5555 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： ドイツ (DEU) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。